Theravance Biopharma
TBPH
TBPH
89 hedge funds and large institutions have $369M invested in Theravance Biopharma in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
Holders
89
Holding in Top 10
1
Calls
$94K
Puts
$28K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$8.88M | |
| 3 | +$5.3M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.2M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$4.13M |
Top Sellers
| 1 | -$9.4M | |
| 2 | -$6.07M | |
| 3 | -$4.45M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$3.41M |